Zomedica Corp. (AMEX: ZOM) Has Fallen -459.62% From Its Highs, What Comes Next? – Marketing Sentinel
Home  »  Business   »  Zomedica Corp. (AMEX: ZOM) Has Fallen -459.62% Fro...

Zomedica Corp. (AMEX: ZOM) Has Fallen -459.62% From Its Highs, What Comes Next?

Zomedica Corp. (AMEX:ZOM)’s traded shares stood at 14.76 million during the last session, with the company’s beta value hitting 0.42. At the close of trading, the stock’s price was $0.52, to imply an increase of 2.06% or $0.01 in intraday trading. The ZOM share’s 52-week high remains $2.91, putting it -459.62% down since that peak but still an impressive 88.46% since price per share fell to its 52-week low of $0.06. The company has a valuation of $468.37M, with an average of 29.67 million shares in intraday trading volume over the past 10 days and average of 27.80 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Zomedica Corp. (ZOM), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ZOM a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Zomedica Corp. (AMEX:ZOM) trade information

After registering a 2.06% upside in the last session, Zomedica Corp. (ZOM) has traded red over the past five days. The stock hit a weekly high of 0.6300 this Thursday, 10/07/21, jumping 2.06% in its intraday price action. The 5-day price performance for the stock is -0.74%, and -9.71% over 30 days. With these gigs, the year-to-date price performance is 125.33%. Short interest in Zomedica Corp. (AMEX:ZOM) saw shorts transact 100.19 million shares and set a 2.5 days time to cover.

Analysts on Wall Street suggest a consensus price target of $1.20, implying an increase of 56.67% to the stock’s current value. The extremes give us $1.20 and $1.20 for target low and target high price respectively. As such, ZOM has been trading -130.77% off suggested target high and -130.77% from its likely low.

Zomedica Corp. (ZOM) estimates and forecasts

Meanwhile, for the quarter ending Jun 2021, a total of 1 analyst(s) estimate revenue growth to $1.1 million.

ZOM Dividends

Zomedica Corp. has its next earnings report out between August 09 and August 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Zomedica Corp. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Zomedica Corp. (AMEX:ZOM)’s Major holders

Zomedica Corp. insiders hold 2.61% of total outstanding shares, with institutional holders owning 15.58% of the shares at 16.00% float percentage. In total, 15.58% institutions holds shares in the company, led by Vanguard Group, Inc. (The). As of Jun 29, 2021, the company held over 42.5 million shares (or 39.34% of shares), all amounting to roughly $35.39 million.

The next major institution holding the largest number of shares is State Street Corporation with 18.37 million shares, or about 17.00% of shares outstanding. As of the market price on Jun 29, 2021, these shares were worth $15.29 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Zomedica Corp. (ZOM) shares. Going by data provided on Jun 29, 2021, Vanguard Total Stock Market Index Fund holds roughly 26.18 million shares. This is just over 24.24% of the total shares, with a market valuation of $21.8 million. Data from the same date shows that the other fund manager holds a little less at 13.8 million, or 12.77% of the shares, all valued at about 11.49 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam